Drug Trial Radar · NCT06462404
A Study to Evaluate the Efficacy, Safety, and Tolerability of E2086 Compared to Placebo and Active Comparator in Adult Participants With Narcolepsy Type 1
Last checked: Nov 19, 2026Latest source record: Jun 4, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
22
Actual
Start
Jun 20, 2024
Primary completion
Mar 17, 2025
Study completion Mar 17, 2025
Sponsor
- Lead sponsor
- Eisai Inc.Eisai
- Sponsor type
- Industry
- First posted
- Jun 17, 2024
Design
- Study type
- Interventional
- Phase
- Phase 1
- Allocation
- Randomized
- Model
- Crossover
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The primary purpose of this study is to evaluate the efficacy of single oral doses of E2086 compared to placebo in the treatment of excessive daytime sleepiness (EDS) as assessed by the Maintenance of Wakefulness Test (MWT) in adult participants with narcolepsy type 1 (NT1).
Conditions
- Narcolepsy Type 1 (NT1)
Interventions
E2086Drug
E2086 oral tablets.
E2086 PlaceboDrug
E2086 matching placebo tablet.
Active ComparatorDrug
Active comparator oral tablets.
Active Comparator PlaceboDrug
Active comparator matching placebo tablet.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Mean Sleep Latency (MSL) as Assessed by the 4 Maintenance of Wakefulness Tests (MWTs) for E2086 Versus Placebo at Day 1Time frame: At Day 1
- MSL as Assessed by the 4 MWTs for E2086 Versus Placebo at Day 5Time frame: At Day 5
- MSL as Assessed by the 4 MWTs for E2086 Versus Placebo at Day 9Time frame: At Day 9
- MSL as Assessed by the 4 MWTs for E2086 Versus Placebo at Day 13Time frame: At Day 13
- MSL as Assessed by the 4 MWTs for E2086 Versus Placebo at Day 17Time frame: At Day 17
Locations
14 sites in 2 countries. Site status is shown where the registry gives one.
SDS Clinical Trials
Santa Ana, California
PharmaDev Clinical Research
Miami, Florida
Sleep Practioners, LLC
Macon, Georgia
Clinical Research Institute
Stockbridge, Georgia
Sound Asleep Research, Inc.
Lansing, Michigan
Research Carolina Elite
Denver, North Carolina
Medical Care Inc.
Goldsboro, North Carolina
Advances Repiratory and Sleep Medicine
Greensboro, North Carolina
Intrepid Research, LLC
Cincinnati, Ohio
Bogan Sleep Consultants, LLC
Columbia, South Carolina
Sleep Therapy and Research Center
San Antonio, Texas
Comprehensive Sleep Medicine Associates
Sugar Land, Texas
AMDX Inc.
Markham, Ontario, Canada
Jodha Tishon Inc
Toronto, Ontario, Canada
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.